{"id":11399,"date":"2022-07-01T20:35:49","date_gmt":"2022-07-02T00:35:49","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/immunotherapy-advances-in-small-cell-lung-cancer\/"},"modified":"2022-07-14T16:15:34","modified_gmt":"2022-07-14T20:15:34","slug":"immunotherapy-advances-in-small-cell-lung-cancer","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/immunotherapy-advances-in-small-cell-lung-cancer","title":{"rendered":"Immunotherapy Advances in Small Cell Lung Cancer"},"content":{"rendered":"<p style=\"text-align: center;\"><iframe loading=\"lazy\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\" frameborder=\"0\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/bNzvnIxsIPo\" width=\"560\"><\/iframe><\/p>\n<p>Small cell lung cancer (SCLC) is aggressive and often difficult to treat, but many patients may have new hope. On August 17, 2018, the <a href=\"https:\/\/www.cancerresearch.org\/blog\/august-2018\/small-cell-lung-cancer-nivolumab-fda-approval\">FDA approved the first immunotherapy&mdash;the checkpoint inhibitor nivolumab (Opdivo&reg;, Bristol-Myers Squibb)&mdash;for patients with small cell lung cancer<\/a>. Since this approval, there has been renewed focus on how to make different immunotherapies work for a disease which&nbsp;typicallly comprises 10-15% of all lung cancer cases.&nbsp;<\/p>\n<p>In this webinar for patients and caregivers, <a href=\"https:\/\/www.mskcc.org\/cancer-care\/doctors\/matthew-hellmann\" target=\"_blank\" rel=\"noopener\"><strong>Matthew Hellmann, MD<\/strong><\/a>,&nbsp;of Memorial Sloan Kettering&nbsp;Cancer Center&nbsp;discusses the new FDA approval, clinical trials, and potential treatments for patients with small cell lung cancer.&nbsp;<\/p>\n<p><img decoding=\"async\" alt=\"Matthew Hellman MSK\" src=\"\/CRI\/media\/Events\/Matthew-Hellmann_sq.png\" style=\"float: left; margin: 10px;\" \/>Dr. Matthew Hellmann specializes in the care of patients with lung cancers. He is dedicated to identifying better treatments for people with all stages of disease and to providing compassionate care for patients and their families. His research focuses on developing innovative and effective ways to harness the body&rsquo;s immune system to fight cancer. He is a member of the Immunotherapeutics Group, which designs and leads early-phase clinical trials of immunotherapies for patients with a variety of different cancers.<\/p>\n<p>The &quot;Cancer Immunotherapy and You&quot; webinar series is produced by the Cancer Research Institute and is hosted by our science writer,&nbsp;<a href=\"https:\/\/www.cancerresearch.org\/our-team\/staff\/arthur-n-brodsky,-ph-d\">Arthur Brodsky, PhD<\/a>&nbsp;This special episode in our webinar series is made possible with generous support from Bristol-Myers Squibb.<\/p>\n<p>Browse our <a href=\"https:\/\/www.youtube.com\/playlist?list=PLiGDIj2dVt-iOiV34MnZIkTiVF3iFgF_o\" target=\"_blank\" rel=\"noopener\">Cancer Immunotherapy and You Webinar Series playlist<\/a> on YouTube or visit the <a href=\"\/events\/webinars\">Webinars page<\/a> on our website to see other webinars in this series.<\/p>\n<p style=\"text-align: center;\"><img decoding=\"async\" alt=\"Bristol-Myers Squibb\" src=\"\/CRI\/media\/Events\/bristol-myers-squibb.png\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Matthew Hellmann of Memorial Sloan Kettering&nbsp;Cancer Center&nbsp;discusses new FDA approvals, clinical trials, and potential treatments for patients with small cell lung cancer.&nbsp;<\/p>\n","protected":false},"featured_media":2315,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11399","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunotherapy Advances in Small Cell Lung Cancer<\/title>\n<meta name=\"description\" content=\"Dr. Matthew Hellmann of Memorial Sloan Kettering\u00a0Cancer Center\u00a0discusses new FDA approvals, clinical trials, and potential treatments for patients with small cell lung cancer.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunotherapy Advances in Small Cell Lung Cancer\" \/>\n<meta property=\"og:description\" content=\"Dr. Matthew Hellmann of Memorial Sloan Kettering\u00a0Cancer Center\u00a0discusses new FDA approvals, clinical trials, and potential treatments for patients with small cell lung cancer.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T20:15:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/51946f66-98c9-4be9-921b-e0a2f5f986e7.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Immunotherapy Advances in Small Cell Lung Cancer\" \/>\n<meta name=\"twitter:description\" content=\"Dr. Matthew Hellmann of Memorial Sloan Kettering\u00a0Cancer Center\u00a0discusses new FDA approvals, clinical trials, and potential treatments for patients with small cell lung cancer.\u00a0\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/51946f66-98c9-4be9-921b-e0a2f5f986e7.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer\",\"name\":\"Immunotherapy Advances in Small Cell Lung Cancer\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/44c0e016-fcd7-4464-a9b9-6f598855b861.jpg\",\"datePublished\":\"2022-07-02T00:35:49+00:00\",\"dateModified\":\"2022-07-14T20:15:34+00:00\",\"description\":\"Dr. Matthew Hellmann of Memorial Sloan Kettering\u00a0Cancer Center\u00a0discusses new FDA approvals, clinical trials, and potential treatments for patients with small cell lung cancer.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/44c0e016-fcd7-4464-a9b9-6f598855b861.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/44c0e016-fcd7-4464-a9b9-6f598855b861.jpg\",\"width\":400,\"height\":267},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Immunotherapy Advances in Small Cell Lung Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunotherapy Advances in Small Cell Lung Cancer","description":"Dr. Matthew Hellmann of Memorial Sloan Kettering\u00a0Cancer Center\u00a0discusses new FDA approvals, clinical trials, and potential treatments for patients with small cell lung cancer.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer","og_locale":"es_ES","og_type":"article","og_title":"Immunotherapy Advances in Small Cell Lung Cancer","og_description":"Dr. Matthew Hellmann of Memorial Sloan Kettering\u00a0Cancer Center\u00a0discusses new FDA approvals, clinical trials, and potential treatments for patients with small cell lung cancer.\u00a0","og_url":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T20:15:34+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/51946f66-98c9-4be9-921b-e0a2f5f986e7.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Immunotherapy Advances in Small Cell Lung Cancer","twitter_description":"Dr. Matthew Hellmann of Memorial Sloan Kettering\u00a0Cancer Center\u00a0discusses new FDA approvals, clinical trials, and potential treatments for patients with small cell lung cancer.\u00a0","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/51946f66-98c9-4be9-921b-e0a2f5f986e7.jpg","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer","url":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer","name":"Immunotherapy Advances in Small Cell Lung Cancer","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/44c0e016-fcd7-4464-a9b9-6f598855b861.jpg","datePublished":"2022-07-02T00:35:49+00:00","dateModified":"2022-07-14T20:15:34+00:00","description":"Dr. Matthew Hellmann of Memorial Sloan Kettering\u00a0Cancer Center\u00a0discusses new FDA approvals, clinical trials, and potential treatments for patients with small cell lung cancer.\u00a0","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/44c0e016-fcd7-4464-a9b9-6f598855b861.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/44c0e016-fcd7-4464-a9b9-6f598855b861.jpg","width":400,"height":267},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/immunotherapy-advances-in-small-cell-lung-cancer#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Immunotherapy Advances in Small Cell Lung Cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/2315"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11399"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11399"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11399"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11399"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11399"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11399"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}